News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hadas Nicole R.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/25/2023 |
4
| Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Sold 63,186 shares
@ $1.2229, valued at
$77.3k
Granted 200,000 options to buy
@ $0.41, valued at
$82k
|
|
| 05/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
4
| Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 03/03/2023 |
4
| Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 5,333 shares
@ $0.8775, valued at
$4.7k
Sold 6,613 shares
@ $0.8775, valued at
$5.8k
Sold 1,088 shares
@ $0.8775, valued at
$954.7 |
|
| 03/01/2023 |
4
| Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 6,677 shares
@ $0.8132, valued at
$5.4k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2019 |
4
| Hadas Nicole R. (SVP, CLO & Secretary) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Disposed/sold 11,929 shares
@ $7.7, valued at
$91.9k
|
|
| 03/05/2019 |
4
| Hadas Nicole R. (SVP, CLO & Secretary) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 65,000 shares
@ $0
Granted 100,000 options to buy
@ $7.28, valued at
$728k
|
|
| 12/13/2018 |
4
| Hadas Nicole R. (SVP, General Counsel, Sec.) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 20,175 shares
@ $8.94, valued at
$180.4k
|
|
| 03/02/2018 |
4
| Hadas Nicole R. (SVP, General Counsel, Sec.) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 17,500 shares
@ $0
Granted 25,000 options to buy
@ $14.3, valued at
$357.5k
|
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/04/2017 |
4
| Hadas Nicole R. (SVP, General Counsel, Sec.) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 1,556 shares
@ $9.1775, valued at
$14.3k
|
|
| 02/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/06/2016 |
4
| Hadas Nicole R. (SVP, General Counsel, Sec.) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 1,557 shares
@ $7.4665, valued at
$11.6k
|
|
| 04/05/2016 |
4
| Hadas Nicole R. (SVP, General Counsel, Sec.) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 1,556 shares
@ $9.41, valued at
$14.6k
|
|
|
|